In the Asia-Pacific medical devices industry, there were 5 private equity deals announced in Q2 2024, worth a total value of $1.4bn, according to GlobalData’s Deals Database. The $839m Institutional Buy-out (IBO) Healthium MedTech by KKR was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in Asia-Pacific decreased in Q2 2024 compared with the previous quarter and as compared to Q2 2023. Related deal volume remained flat in Q2 2024 versus the previous quarter.
The top-ranked financial advisors supporting these private equity deals in Asia-Pacific in H1 2024 were Jefferies Financial Group; Moelis & Co; Nuvama Wealth Management with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in Asia-Pacific in H1 2024 were AZB & Partners; Kirkland & Ellis; Simpson Thacher & Bartlett with 2, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.